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Abstract
Background: The active form (T3) of thyroid hormone (TH) controls critical aspects of cerebellar development, such
as migration of postmitotic neurons and terminal dendritic differentiation of Purkinje cells. The effects of T3 on
early dendritic differentiation are poorly understood.
Results: In this study, we have analyzed the influence of T3 on the progression of the early steps of Purkinje cell
dendritic differentiation in postnatal day 0 organotypic cerebellar cultures. These steps include, successively,
regression of immature neuritic processes, a stellate cell stage, and the extension of several long and mature
perisomatic protrusions before the growth of the ultimate dendritic tree. We also studied the involvement of
RORa, a nuclear receptor controlling early Purkinje cell dendritic differentiation. We show that T3 treatment leads to
an accelerated progression of the early steps of dendritic differentiation in culture, together with an increased
expression of RORa (mRNA and protein) in both Purkinje cells and interneurons. Finally, we show that T3 failed to
promote early dendritic differentiation in staggerer RORa-deficient Purkinje cells.
Conclusions: Our results demonstrate that T3 action on the early Purkinje cell dendritic differentiation process is
mediated by RORa.
Background
The thyroid hormone (TH) L-3,3’,5-triiodothyronine
(T3) is essential for normal central nervous system
development [1], regulating processes associated with
brain differentiation, such as neuronal migration, axonal
and dendritic growth, synaptogenesis, and myelination
[2]. In particular, TH plays an important role in cerebel-
lar neurogenesis [3-5], a mainly postnatal developmental
process. As a consequence, perinatal hypothyroidism
affects the morphogenesis of cerebellar neurons (in par-
ticular the dendritic arborization of the Purkinje cells
(PCs), which display a striking reduction in the growth
and branching of their dendritic arborization [6]) and
delays synaptic formation between PCs and granule cells
[3-5,7] (for review, see [8]). Recent studies have demon-
strated that THs promote this growth of the PC mature
dendritic tree through activation of the nuclear thyroid
hormone receptor (TR) TRa1 [9,10].
Shortly after birth, cerebellar PCs display a bipolar
shape reminiscent of their migratory morphology. These
immature PCs then follow a process of dendritic regres-
sion, prior to extending dendrites from which the ulti-
mate and characteristic mature dendritic tree will arise
(for review, see [11]). We have recently demonstrated
that the nuclear receptor Retinoic acid receptor-related
orphan receptor alpha (RORa, NR1D1) controls the
early dendritic differentiation steps, particularly the
regressive phase of this process [12]. The loss-of-func-
tion staggerer (sg) mutation in the Rora gene leads to
cerebellar developmental defects in the mouse, including
dramatic PC and granule cell loss [13-16]. Interestingly,
cross-talk between the TH pathway and RORa has been
shown. In hypothyroid rats, daily thyroxine (T4) replace-
ment accelerates the increase of RORa mRNA within
the developing cerebellum, most obviously at P15 [17].
In the homozygous staggerer mutant mouse (Rora
sg/sg),
despite both normal TR expression [14] and normal
serum TH levels [18], staggerer neurons seem to be
unresponsive to TH treatment [19].
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alities due to hypothyroidism, most studies investigate
the role of TH in the growth of the mature PC dendritic
tree, which involves cross-talk and synaptogenesis with
granule cells; but little is known about the effect of TH
on early dendritic differentiation. In this study, we
aimed at determining the role of TH in early PC dendri-
tic differentiation, that is, during the phase of regression
of the primary dendrite, and we studied the involvement
of RORa in this process. Using organotypic cultures, we
have thus studied the progression of PC dendritic differ-
entiation in the presence or absence of T3,a n dw e
observed an acceleration of the process of dendritic dif-
ferentiation when T3 was added onto postnatal day 0
(P0) cerebellar slices for both early events (regression of
the primary dendrite observed after 3 days in vitro
(DIV)) and later ones (growth of the mature dendritic
tree). We further propose that the accelerated early den-
dritic differentiation is dependent on a T3-induced
increase of RORa expression.
Results
Determination of the optimal T3 concentration to
promote PC dendritic growth in organotypic culture
At birth, in vivo, most murine PCs are fusiform (bipolar
shape, stage I; data not shown), as described for rats
[20]. When cultured at P0 and kept in organotypic cul-
tures, PCs present first an immature morphology (bipo-
lar fusiform, stage I), then retract their primitive
dendrites to become stellate or atrophic (stage II), elon-
gate numerous long and mature dendritic perisomatic
protrusions (stage III), and finally develop their ultimate
dendritic trees (stage IV) [12].
In organotypic cultures, after 7 days in a serum-con-
taining medium, PCs were mostly in stage II (stellate or
atrophic stage), whereas almost no stage III PCs were
observed. In order to explore the involvement of T3 in
dendritic differentiation (that is, before the extension of
the ultimate dendritic tree in stage IV), cultures from P0
animals were prepared and kept 7 DIV under serum-
free conditions, with or without addition of T3 at
different concentrations. Cultures were then fixed and
immunolabeled with an anti-calbindin (anti-CaBP) anti-
body to visualize PCs.
In P0 slices cultivated without T3,m o s tP C s( 7 6 % )d i s -
played ‘stellate or atrophic’ dendrites after 7 DIV (stage
II; Figure 1A,B). Adding T3 at a concentration of 3 nM
did not dramatically modify the repartition of PC classes
(Figure 1C,D). In contrast, supply of 30 nM of T3 led to a
significant acceleration of the dendritic differentiation
s i n c ew eo b s e r v e dt h a to n l y2 7 %o fP C sw e r ei ns t a g eI I ,
whereas 39% displayed long dendritic perisomatic protru-
sions and were thus classified as stage III PCs, and 34%
displayed an identified mature dendritic tree (stage IV;
Figure 1E,F). Increased concentration of T3 (100 nM)
also led to an acceleration of the dendritic differentiation
(compared to 0 nM and 3 nM of T3), although this treat-
ment was not as efficient as 30 nM T3 since the propor-
tion of stage IV PCs was lower (Figure 1G,H). Thus,
these results show that, in organotypic culture, as already
demonstrated for dissociated cell culture [10,11], the
addition of T3 to the culture medium promotes PC den-
dritic development in a dose-dependent manner. In the
following experiments, we have used the 30 nM concen-
tration to assess the effects of T3 since this concentration
is the most efficient in our culture conditions.
T3 leads to an increased amount of RORa protein in PCs
and interneurons
To determine whether the T3-induced acceleration of
dendritic differentiation involves RORa, we first assessed
RORa expression in cerebellar slices in response to T3
treatment. By combination of promoter usage and alter-
native splicing, the Rora gene encodes two isoforms in
the mouse (RORa1a n dR O R a4), which differ only in
their amino-terminal modulator region [21-23].
Western blots of P0 7 DIV cerebellar slices were per-
formed with antibodies directed against the carboxyl ter-
minus of RORa, which can detect both RORa1a n d
RORa4 isoforms. We detected an increase of 6.8-fold
in the amount of RORa1 protein in slices treated with
30 nM of T3 (Figure 2A).
In the cerebellum, RORa is known to be expressed
only in PCs and interneurons [24]. In order to deter-
mine in which cell type the upregulation of RORa
expression occurs, we used immunofluorescence to
detect and locate the RORa p r o t e i ni no r g a n o t y p i cc u l -
t u r e s .S i n c eo n l yP C si nt h ec e r e b e l l u me x p r e s sC a B P ,
we used CaBP as a PC-specific marker, and we used
parvalbumin as a marker of interneurons. Both mature
interneurons and PCs express parvalbumin: interneurons
were unambiguously identified as parvalbumin-positive
and CaBP-negative cells.
To assess whether T3 led to increased expression
RORa1 in PCs, we quantified the fluorescence density
of RORa labeling within the nucleus of PCs. We
observed a significant increase in the fluorescence den-
sity in T3-treated slices compared to control T3-
untreated slices (Figure 2B). Interestingly, following T3
treatment, RORa labeling was observed in PCs and also
in some CaBP-negative cells. Some CaBP-negative cells
that express RORa also expressed parvalbumin, and
were thereby identified as interneurons (Figure 2B).
Therefore, T3 treatment led to increased expression
of RORa in both PCs and parvalbumin-positive
interneurons.
To determine whether the increase in RORa protein
levels in T3-treated cerebellar slices is the consequence of
Boukhtouche et al. Neural Development 2010, 5:18
http://www.neuraldevelopment.com/content/5/1/18
Page 2 of 11increased expression of the Rora gene, and not stabiliza-
tion of the protein, we analyzed by real time RT-PCR the
mRNA level of the different Rora isoforms in the T3-trea-
ted slices compared to untreated slices after 7 DIV (Figure
2C). A 3.3-fold increase was observed for Rora1 after 7
DIV. The Rora4 mRNA level was similar to untreated
slices after 7 DIV. These results show that T3 leads to
increased expression of the Rora1 isoform after 7 DIV.
These results show that T3 induced increased RORa1
protein levels in PCs in parallel with their dendritic dif-
ferentiation after 7 DIV.
T3 accelerates the first steps of early PC dendritic
differentiation and increases Rora gene expression at P0
As we previously demonstrated that RORa is involved
in early dendritic differentiation [12], we examined
whether T3 promotes this early change. We thus
assessed the effect of T3 treatment on cerebellar slices
a f t e r3D I V ,at i m ew h e nP C sc u l t u r e dw i t h o u tT 3 dis-
play mainly bipolar fusiform dendritic morphology
(stage I; 97%) whereas very few are in a stellate or
atrophic morphology (stage II; 3%; Figure 3A). In the
presence of 30 nM of T3 after 3 DIV, all PCs were still
Figure 1 Dose-dependent effect of T3 on PC dendritic differentiation in organotypic cultures. (A-H). Organotypic cultures of P0 cerebella
were kept 7 DIV in the absence of T3 (A,B), or in the presence of 3 nM T3 (C,D), 30 nM T3 (E,F) or 100 nM T3 (G,H). (A,C,E,G) PCs were revealed
by CaBP immunolabeling. (B,D,F,H) Quantitative distribution of PCs between stages I to IV. Fusiform PCs with a bipolar shape are defined as
stage I (arrow in (A,C)), PCs with regressive atrophic dendrites all around the soma are defined as stage II (white arrowhead in (A,C)), PCs with
one or more perisomatic protrusions are defined as stage III (empty arrow in (G)) and PCs with an identified dendritic tree are classified as stage
IV (empty arrowhead in (E)). Scale bar = 20 μm. Error bars indicate mean ± standard deviation.
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PCs in stage II (28%; Figure 3A) compared to the con-
trol without T3 (3%; Figure 3A). From those experi-
ments, we can conclude that T3 promotes the first
dendritic differentiation steps of PCs from stage I to
stage II in organotypic cultures.
To determine whether T3 increases Rora expression in
early stages of PC development, we analyzed the mRNA
levels of the Rora isoforms in response to T3 treatment
during the first day of culture (Figure 3B). We observed
as p e c i f i ci n c r e a s ei nt h eRora1 mRNA level after 6 h
and 24 h of T3 treatment (6.5- and 5.7-fold increase,
respectively). The Rora4 mRNA level was slightly and
transiently increased in slices after 24 h of T3 treatment
(1.7-fold increase). These results show that T3 leads to
increased expression of the Rora1 isoform in fusiform
PCs at P0 and, to a lesser extent, of the Rora4 isoform.
Interestingly, our results also revealed that mRNA levels
of both Rora1 and Rora4 isoforms were stable in cul-
tures made at P0 and kept for 6 h, 24 h and 7 DIV in
culture without T3 (compare Figures 2C and 3B).
T3-induced early dendritic differentiation involves RORa
The experiments described above show that T3 pro-
motes dendritic differentiation (Figures 1 and 3) and
leads to increased expression of RORa1( F i g u r e s2a n d
3). We have recently shown that RORa is a crucial fac-
tor controlling the early steps of PC dendritic differen-
tiation, and staggerer RORa-deficient PCs do not
progress beyond early bipolar migratory morphology
Figure 2 T3 treatment increases the amount of RORa protein and RNA in organotypic cultures. P0 cerebellar slices kept for 7 DIV were
cultured in the absence or the presence of 30 nM T3. (A) Immunoblot analysis and quantification of RORa levels in extracts of untreated or T3-
treated cerebellar slices (*P < 0.05). (B) Left panel: fluorescence density of RORa immunolabeling was measured within each PC nucleus with
MetaMorph software. Average values from multiple cells ± SEM are shown (*P < 0.05). Right panel: organotypic cultures after 10 DIV without T3
(upper row) or with T3 (30 nM) treatment (lower row). RORa-expressing cells were revealed by RORa immunolabeling (blue), PCs were revealed
by CaBP immunolabeling (red) and both PCs and interneurons were revealed by parvalbumin immunolabeling (green). Note the presence of
RORa-expressing interneurons (arrow) in the T3 only treatment. (C) P0 organotypic cultures were cultured without T3 (white bars) or with 30 nM
T3 (black bars) for 7 days. Levels of mRNA were determined by real time RT-PCR and standardized to 18 s rRNA The data are given relative to
the mRNA level in untreated slices at the initial time of the culture (0 DIV). They were obtained from three independent cerebellar slices extracts
(*P < 0.05; **P < 0.005). Error bars in (C) indicate mean ± standard deviation.
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in the T3-induced PC dendritic differentiation, we fol-
lowed the progression of the dendritic differentiation of
PCs from staggerer (Rora
sg/sg) and corresponding control
Rora
+/+ cerebellar slices treated or not with T3.
As previously observed in serum-containing cultures
[12], PCs from Rora
sg/sg cultured in serum-free medium
display the embryonic bipolar shape (stage I) after 7
DIV (Figure 4B), whereas most PCs in control Rora
+/+
cultures display ‘regressive-atrophic’ dendrites (stage II;
Figure 4A). In the presence of 30 nM T3, stage II, III
and IV PCs were found (Figure 4C) with the same pro-
portions as described in Figure 1. In contrast, PCs from
Rora
sg/sg animals still display embryonic bipolar shape
(Figure 4D) with long processes characteristic of stage I
PCs [12], indicating that they were not responsive to T3
treatment and remained in the very early stage of den-
dritic differentiation.
The absence of a functional RORa protein thus pre-
vents T3-induced accelerated dendritic differentiation of
immature bipolar P0 PCs. This experiment shows that
RORa is required in the T3-induced dendritic differen-
tiation-promoting process.
T3 up-regulates the activity of the Rora promoter
To gain further insight into the mechanism by which T3
up-regulates Rora gene expression, we tested the effect
of T3 on the transcriptional activity of the p(-487)Rora-
Luc construct in HepG2 cells, which shows 82.9%
sequence homology with the murine sequence and has
been previously used as a model to analyze the tran-
scriptional regulation of the Rora gene [25] (Additional
file 1). T3 treatment resulted in a 3.6-fold increase in
the activity of the p(-487)Rora-Luc construct compared
to its basal activity in the absence of T3 (Figure 5). Plas-
mid pDR4-TK-Luc, which contains a thyroid receptor
response element (DR4), was used as a control for the
effect of T3 on transcriptional activity. As expected, the
luciferase activity of pDR4-TK-Luc was strongly
increased (12.1-fold) by T3 treatment, indicating that T3
is active under our experimental conditions.
Taken together, the results of these experiments indi-
cate that the effect of T3 on Rora expression is, at least
in part, transcriptional and that the -487 to -45 Rora
promoter region is involved in this regulation.
Discussion
Our results show for the first time that T3 promotes the
early steps of PC dendritic differentiation, during the
phase of neurite regression that precedes the formation
of the ultimate dendritic tree. Addition of T3 to the
serum-free medium of P0 cerebellar slices resulted in an
acceleration of the early steps of dendritic differentia-
tion. This accelerated progression of dendritic
Figure 3 T3 promotes the early dendritic differentiation of PCs and leads to increased mRNA levels of Rora1 and Rora4 at P0. (A)
Quantitative distribution of PCs between stages I and IV. Cultures of P0 cerebella were kept 3 DIV in the absence or the presence of 30 nM T3.
PCs are classified following the same criteria as in Figure 1. (B) P0 organotypic cultures were cultured without T3 (white bars) or with 30 nM T3
(black bars). Levels of mRNA were determined by real time RT-PCR and standardized to 18 s rRNA after 0 h, 6 h or 24 h of T3 treatment. The
data are given relative to the mRNA level in untreated slices at the initial time of the culture (0 h). They were obtained from three independent
cerebellar slice extracts (**P < 0.005; *** P < 0.0005). Error bars indicate mean ± standard deviation.
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of the gene encoding the nuclear receptor RORa,
observed at both mRNA and protein levels. We further
show that the RORa protein is required for the T3-
induced early dendritic differentiation, as T3 treatment
did not promote dendritic differentiation in Rora
sg/sg
PCs. This result is in accordance with previous studies
that suggest an unresponsiveness of Rora
sg/sg mutants to
TH [19].
T3 promotes early PC dendritic differentiation
The role of TH in mammalian brain is well documen-
ted, particularly during cerebellar development (for
review, see [1,26]). Congenital hypothyroidism in
humans leads to a syndrome termed cretinism [27], the
apparent symptoms of which include ataxia and poor
motor skills, indicating cerebellar defects. In PCs, TH is
known to strongly promote differentiation of the elabo-
rate dendritic tree and synapse formation. In contrast,
little is known about its role in the events preceding the
development of the ultimate dendritic tree, in particular
the steps of neuritic regression and early extension of
perisomatic protrusions, occurring in vivo in the rodent
between P0 and P7.
To better understand the effect of TH action in the
developing brain, the temporal patterns of initiation and
cessation of hormone action need to be determined.
Most in vitro or in vivo experiments explore the effects
of hypo- or hyperthyroidism in the cerebellum from
P15, or its equivalent age in culture. At this age, the
characteristic shape of the dendritic arborization is
already achieved, and extrinsic factors such as electrical
activity [28] from granule cells, trophic factors [29-32]
and TH modulate the growth of the dendritic arboriza-
tion [4]. Studies have shown a role for TH in the persis-
tence of the external granular layer and the migration of
granule cells into the internal granular layer [4,5,33], in
the proliferation and differentiation of interneurons [34],
as well as a direct role of TH on PCs through TRa1
receptor activation [10]. However, the effects of TH on
PC dendritic differentiation during early steps that do
not require cell-cell interaction have not been shown.
Using P0 slices after 3 DIV, we could specifically
assess the role of TH in early development, and our
results show that T3 also plays a key role in the early
dendritic differentiation of PCs in organotypic cultures,
that is, before the formation of the elaborated dendritic
tree. These data extend the well-known role of T3 in the
later stages of PC dendritic differentiation [6,8-10] and
identify a third molecule besides RORa and SCLIP
[12,35] involved in the first steps of PC dendritic
Figure 4 T3 treatment fails to induce dendritic differentiation
in early RORa-deficient staggerer PCs in organotypic cultures.
(A-D) PCs in organotypic cultures from wild-type (A,C) or RORa-
deficient Rora
sg/sg (B,D) P0 mice were revealed by CaBP
immunolabeling after 7 DIV without T3 (A,B) or with 30 nM T3 (C,D).
PCs from wild-type mice responded to T3 treatment: without T3, PCs
were mostly in stage II (PCs with regressive-atrophic dendrites all
around the soma) whereas they were in stages II, III (empty arrows)
and IV (empty arrowheads) after 30 nM T3 treatment (C). PCs from
Rora
sg/sg mice were unresponsive to T3 treatment since they remain
in stage I (fusiform PCs with long processes of bipolar shape) in the
absence (B) or in the presence (D) of 30 nM T3 treatment. Note the
bipolar or fusiform shape of the PCs with long processes but no
dendritic arborization in (B,D). Scale bar = 20 μm.
Figure 5 T3 treatment upregulates Rora promoter activity.
HepG2 cells cultured in 12-well plates were co-transfected with
500 ng/well of the pTRa vector, allowing expression of the TR, and
500 ng/well of the p(-487)Rora-Luc reporter vector, which allows
expression of the luciferase gene under the control of the human
genomic sequences between nucleotides -487 and -45 from the
Rora1 translation initiation site, or with 500 ng/well of the promoter-
less pGL3-Luc vector. HepG2 cells co-transfected with 500 ng/well
of the pTRa vector and of the pDR4-TK-Luc reporter vector were
used as a control of the transcriptional effect of T3 on a TH
response element. The luciferase activity of p(-487)Rora-Luc and
pDR4-Luc in the absence or the presence of T3 (30 nM) is expressed
relative to that of the promoter-less pGL3-Luc vector (*P < 0.05).
Error bars indicate mean ± standard deviation.
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tor described to play a role in these processes.
We also show that T3 promotes the expression of both
RORa and parvalbumin in interneurons, which corrobo-
rates recent results from Manzano et al. [34], who have
shown that TH acts on the proliferation and differentia-
tion of interneuron precursors in the cerebellum [34].
Further studies will be required to determine whether the
TH action on interneurons is mediated by RORa.
Cross-talk between RORa and the TH pathway
Interestingly, T3 addition led to increased expression of
RORa in the cerebellar PCs and interneurons. This
result is in accordance with previous studies that
showed decreased expression of RORa in the cerebel-
lum of hypothyroid rats [36], whereas T4 replacement
led to increased expression [17].
Our results indicate that RORa1 expression is
required for the T3-induced effect on early dendritic dif-
ferentiation. Further, we show that the activity of the
Rora promoter was enhanced by T3 treatment in cul-
ture, suggesting that TH acts on the process of early
dendritic differentiation through increased expression of
the Rora gene. TH binds to the nuclear TH receptor
(TR), a ligand-regulated transcription factor, which then
binds to a target DNA sequence known as a TH
response element (TRE) within the promoter region of
target genes. Further studies are needed to determine
whether RORa is a target gene of TR, and whether the
transcriptional effect observed in our study is under
direct control. An additional level of interaction between
RORa and TR has been demonstrated by Koibuchi and
collaborators [37,38], who showed that RORa1 increases
TR-induced transactivation on several TREs. This could
account for the RORa requirement in the T3-mediated
promotion of PC dendritic differentiation observed in
this study. TR binds as a monomer, homodimer, or het-
erodimer (particularly with retinoid × receptors) to the
TRE, which is composed of two half-site core motifs
(AGGTCA) with specific nucleotide spacing and orien-
tation. RORa binds as a monomer to a consensus motif
composed of a 6-bp AT-rich sequence 5’ to a half-site
core motif, AGGTCA (ROR-response element, RORE),
to activate transcription [23]. Both TR and RORa are
thus transcription factors that share the common core
motif within their response elements. RORa1i sa b l et o
bind as a monomer to one of two core motifs
(AGGTCA) of a TRE that is preceded by an AT-rich
sequence [23,37]. This suggests that a subset of natural
TREs containing appropriate AT-rich sequences could
serve as dual-response elements for TR and RORa.
Because of the high homology between the human and
murine RORa1 coding and promoter sequences, it is
possible that RORa mediates some TH actions in
human. Beside its roles in the developing cerebellum,
RORa has also been shown to play critical roles in
many different tissues and systems, including immunity,
cancer, cellular metabolism, circadian rhythm, develop-
ment and ageing (for review, see [39]). Understanding
the roles of RORa could therefore provide further infor-
mation about the pleiotropic effects of late prenatal or
early postnatal hypo- and hyperthyroidism in humans.
Intrinsic effect of RORa, and potential coordination with
TH in the PC dendritic differentiation process
RORa has been shown to be crucial for the progression
of early differentiation of PCs in a cell-autonomous
manner [12]. In cerebellar slices, T3 is likely to act on
RORa expression within PCs. Our results extend pre-
vious studies of Heuer and Mason [10], which clearly
demonstrated that PCs are a direct target of TH action
through activation of TRa1: TH promotes the late
stages of the elaboration of PC dendritic arborization,
which is also dependent upon granule cell differentiation
and synaptogenesis. Interestingly, RORa has been shown
to control the expression of Sonic hedgehog (Shh)i n
PCs, which in turn promotes the proliferation of granule
cells precursors in the external granular layer [40]. Thus,
a coordinate mechanism involving RORa and TH in
cerebellar development can be proposed in which both
T3 and RORa act on PC dendritic differentiation
directly as well as indirectly via the promoting effect on
granule cell development. However, the later and direct
effects of T3 on early PC differentiation are unlikely to
be mediated by RORa since we have shown that RORa
does not influence this later step of differentiation [12].
In its homozygous state, the murine staggerer muta-
tion of the Rora gene leads to cerebellar atrophy due to
the degeneration of most PCs [13,15,41-43]. Several his-
tological studies of the Rora
sg/sg cerebellum show that
the remaining PCs are immature and display atrophic
dendrites, devoid of spines [44-46]. These abnormalities
of dendritic differentiation observed in homozygous
staggerer mice are similar to, but worse than, those
observed in hypothyroid rats. This implies that RORa
acts on additional processes in cerebellar development,
apart from those induced by THs. This hypothesis is
strengthened by the recently demonstrated neuroprotec-
tive role of RORa at least partly through its control of
oxidative stress mechanisms [16,47].
In conclusion, our results show that RORa plays a cri-
t i c a lr o l ei nt h ee a r l yT 3-induced dendritic differentia-
tion of PCs.
Materials and methods
Animals
Animal housing and all procedures were carried out in
accordance with the guidelines of the French Ministry
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mice were obtained from Janvier (Le Genest-St-Isle,
France). The staggerer Rora
sg/sg mutant mice were main-
tained on a C57BL/6J genetic background in our colony.
Rora
sg/sg and their Rora
+/+ littermates were obtained by
intercrossing fertile heterozygous Rora
+/sg animals, and
were genotyped by PCR, as previously described [12].
Organotypic slice cultures
Swiss mice at P0 were used. Organotypic cultures of
cerebellum were prepared as described previously [48].
Briefly, after decapitation, brains were dissected out into
cold Gey’s balanced salt solution (Sigma, Lyon, France)
supplemented with 5 mg/ml glucose, and the meninges
were removed. Parasagittal cerebellar slices (350 μm
thick) were cut on a McIlwain tissue chopper (Stoetling
Europe, Dublin, Ireland) and transferred onto 30 mm
Millipore membrane culture inserts with a 0.4 μmp o r e
size (Millicell CM, Millipore, Molsheim, France). Slices
were maintained in culture in six-well plates containing
1 ml per well of medium containing basal medium with
Earle’s salts (BME), supplemented with Sigma I-1884
supplement (1:100 dilution, resulting in final concentra-
tions of 5 μg/ml insulin, 5 μg/ml transferrin, and
5 ng/ml sodium selenite), 0.5 μg/ml BSA (Sigma), 4 mM
L-glutamine (Invitrogen, GIBCO, Cergy Pontoise,
France), 5 mg/ml glucose, with or without T3 at 37°C in
a humidified atmosphere with 5% CO2.T h em e d i u m
was replaced every 2 days (after 2, 4 and 6 days in
culture).
Mice obtained from Rora
+/sg intercrosses were also
used in this study. In these litters, Rora
+/+, Rora
+/sg and
Rora
sg/sg mice could be generated. For each animal,
slices of each cerebellum were divided between two
Millicells: half of the cerebellar slices served as controls
and no T3 was added and the other half were treated
with T3 (30 nM) in order to compare control (0 nM T3)
versus T3-treated slices (30 nM T3)f r o mt h es a m ea n i -
mals. The genotype was determined a posteriori by PCR
on tail biopsy, in blind studies.
Antibodies and staining procedures
Immunostaining of CaBP, parvalbumin or RORa was
performed as described previously [12]. Briefly, cerebel-
lar slices were fixed in 4% paraformaldehyde, and then
incubated for 1 h in phosphate-buffered saline contain-
ing 0.25% Triton X-100, 0.2% gelatin, 0.1% sodium azide
(PBSGTA) and 0.1 M lysine. Rabbit polyclonal or mouse
anti-CaBP antibody (1:5,000 dilution; Swant, Switzer-
land) to visualize PCs, or rabbit polyclonal anti-parval-
bumin (1:5,000 dilution; Swant) to visualize both PCs
and interneurons, and goat polyclonal anti-RORa1
(sc-6062; 1:4,000 dilution; Santa-Cruz, Tebu-Bio SA, Le
Perray en Yvelines, France) in PBSGTA were applied
overnight. At this dilution, the intensity of RORa label-
ing was correlated to the RORa expression level [12].
Specific labeling was detected with Cy3-conjugated don-
key anti-rabbit antibody (1:500 dilution; Jackson Immu-
noresearch, Immunotech, Marseille, France) and FITC-
conjugated donkey anti-goat antibody (1:2,000 dilution;
Jackson Immunoresearch). The slices were analyzed
with an inverted microscope (Nikon Eclipse TE 300).
Immunofluorescence images were captured at 400×
magnification using a Qimaging Retiga 1300 camera,
and analyzed using Image-Pro Plus 4.1 software (Media
Cybernetics, Bethesda, MD, USA). For RORa fluores-
cence intensity measurements, fluorescence density was
measured in the nucleus of PCs (visualized by CaBP
immunolabeling) using MetaMorph software.
Classification of PC dendritic differentiation stages
Classification of PCs was assessed after CaBP immunos-
taining, as previously describ e d[ 1 2 ] .B r i e f l y ,f u s i f o r m
PCs with a bipolar shape, reminiscent of embryonic
migratory PCs, are defined as stage I and correspond to
both ‘simple’ and ‘complex’ fusiform stages, observed
from embryonic day 16 to P4 in vivo [20]. Stage II com-
prises PCs with short processes all around the soma.
This ‘stellate’ stage includes both ‘regressive-atrophic
dendrites’ and ‘stellate cell’ stages described previously,
from P2 to P6 in vivo. PCs with more than one long
and mature dendritic protrusion are defined as stage III.
They correspond to PCs around P5 to P10 in vivo.
Finally, PCs with one well identified dendritic tree
(defined as primary dendrites giving rise to additional
side branches) are classified as stage IV. Images were
taken from all slices, corresponding to at least 200 PCs
in each experiment. Quantification was performed on
three independent experiments.
Western-blot analysis
Cultured slices were lysed in solubilization buffer
(500 mM NaCl, 1 mM MgCl2,2m ME G T A ,5 0m M
B i c i n e ,p H9 . 0 ,5 0m MN a F ,5μMZ n C l 2,1 0 0μM
Na3VO4, 1 mM dithiothreitol, 5 nM okadaic acid, 2.5
μg/ml aprotinin, 3.6 μM pepstatin, 0.5 μMp h e n y l -
methylsulfonyl fluoride, 0.5 mM benzamidine, 5.3 μM
leupeptin) and dounced at 4°C. Insoluble materials were
removed by centrifugation (13,000 g for 20 minutes at
4°C), supernatants were isolated and the samples were
stored at -80°C. Proteins were dosed with the DC pro-
tein assay kit (Bio-Rad, Hercules, CA, USA). As pre-
viously described [49], cell-extracts containing
equivalent amounts of protein were boiled for 5 minutes
in sample loading buffer. After a 10% SDS-PAGE, pro-
teins were transferred to a polyvinylidene difluoride
membrane (ICN Biochemicals, Costa Mesa, CA USA).
Non-specific sites were blocked with 5% skimmed dried
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Page 8 of 11milk for 2 h. Blots were then incubated overnight at 4°C
with primary antibodies against RORa (1:2,000; Santa
Cruz) and a-tubulin (1:10,000; Sigma) in 5% skimmed
dried milk. They were then incubated with horseradish
peroxidase-conjugated secondary antibodies in 5%
skimmed dried milk for 1 h. The revelation was pro-
cessed with enhanced chemoluminescence substrate
(Amersham, Saclay. France). Quantification was per-
formed using Densylab software (Microvision Instru-
ments, Evry, France).
Real-time RT-PCR
Total RNA from cerebellar slices from three animals
was prepared according to the manufacturer’si n s t r u c -
tions using the RNeasy kit (Qiagen, Courtaboeuf,
France) and cDNAs were synthesized from 1 μgo fR N A
(Promega, Charbonnieres-les-Bains, France) and avian
myeloblastosis virus (AMV) reverse transcriptase, as per
the manufacturer’s instructions.
RT-PCR was performed using the ABsolute™ QPCR
SYBR® Green Mixes Kit (ABgene, Courtabeoeuf,
France), as per the manufacturer’si n s t r u c t i o n s .R e a c -
tions were performed in 25 μl of total volume contain-
ing ABsolute™ QPCR SYBR® Green Mix with 8 ng of
the first-strand cDNA and 300 nM of primers. The fol-
lowing primers were used: Rora1 sense, 5’-AGGCA-
GAGCTATGCGAGC-3’,a n da n t i s e n s e ,5 ’-
TCAAACAGTTCTTCTGACGAGG-3’; Rora4 sense,
5’-GTCACATGGAGCC TCTTATGG-3’,a n da n t i -
sense, 5’-TCAAACAGTT CTTCTGACGAGG-3’;1 8s
sense, 5’-GGGAGCCTGAGAAACGGC-3’,a n da n t i -
sense, 5’ GGGTCGGA GTGGGTAATTT-3’.A m p l i f i -
cation was performed on an iCycler (Bio-Rad)
according to the manufacturer’s instructions and cycle
parameters were: 50°C (2 minutes) and 95°C (10 min-
utes), followed by 40 cycles of 95°C (15 s), 60°C (30 s)
and 72°C (30 s). For expression quantification, a com-
parative CT method was used [50,51]. The ΔCT value
was obtained by subtracting the CT value of the 18 S
(reference) from the CT value of the gene of interest,
where in each case the mean value of three reactions
was used. For each gene, the fold change was calcu-
lated according to the formula 2
() CT ,w h e r eΔΔCT
was the difference between the ΔCT of T3-treated cul-
tures and the ΔCT of untreated cultures as a calibrator
value. To distinguish specific amplicons from non-spe-
cific amplifications, a dissociation curve was generated
for each transcript. Quantification was performed on
three independent experiments.
Vectors, transient transfection and luciferase assay
The plasmid p(-487)Rora-Luc contains the luciferase
reporter gene placed under the control of the promoter
region of the human Rora gene, from -487 to -45
relative to the Rora translation initiation site [25]. The
vector pTRa, containing mouse TRa1 cDNA, cloned in
plasmid pSG5 and plasmid pDR4-TK-Luc, which con-
tains a TRE in front of the promoter of the thymidine
kinase gene of the herpes simplex virus controlling
expression of the luciferase gene where kind gifts of
Dr F Flamand (Ecole Normale Superieure, Lyon,
France).
The promoter-less pGL3-basic luciferase reporter vector
(pGL3-Luc) was from Promega. Transient transfection
experiments were done with HepG2 human hepatoma
cells using the calcium phosphate method. Twenty-four
hours after the transfection, 30 nM of T3 were added to
the medium and the luciferase activity was assayed 24 h
later, as described [25]. Activities corresponding to cells
cultured with 30 nM of T3 were expressed relative to
those of control cells cultured without T3.
Statistical analysis
Independent experiments were performed with 10 to 12
cerebellar slices per sample and repeated three times
using matched controls. For PC stage quantification, at
least 200 PCs were analyzed in each sample. For the
RORa RNA level quantification by real-time PCR, all
slices of three animals were used in each experiment.
Results are expressed in Figures as mean ± standard
deviation. The statistical significance of differences
between control and T3-treated slices was assessed by a
Student’s t-test using Statview software (SAS Institute
Inc., Berkeley, CA, USA).
Additional material
Additional file 1: Sequence comparison of the human and mouse
RORa1 promoter region. Human and mouse sequences of the
immediately upstream region of the translation initiation codon (+1) of
the Rora gene and including the -487 to -45 Rora promoter region
(boxed area) were aligned using ClustalW software. The sequence
downstream of the initiation codon corresponds to the beginning of
exon 1. The nucleotide sharing identity across both species are indicated
by asterisks and gaps are indicated with hyphens. The -487 to -45
human sequence shows 82.9% identity across species. Both human and
murine sequences were obtained from the GenBank database: Homo
sapiens chromosome 15 genomic contig [NT_010194.17], 32312505 to
32311809 bp; Mus musculus chromosome 9 genomic contig, strain
C57BL/6J [NT_039474.7|Mm9_39514_37], 14921696 to 14922363 bp).
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